Coronavirus disease 2019 and obstructive sleep apnea syndrome
Yazarlar (3)
Prof. Dr. Ahmet Cemal PAZARLI Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Timur Ekiz
Türkmenbaşı Medical Center, Türkiye
Türkmenbaşı Medical Center, Türkiye
Faik İlik Medicana Hospital, Türkiye
| Makale Türü |
Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği,
araştırma notu, bilirkişi raporu ve benzeri)
(SCI, SSCI, AHCI, SCI-Exp dergilerinde yayınlanan teknik not,
editöre mektup, tartışma, vaka takdimi ve özet türünden makale)
|
||
| Dergi Adı | Sleep and Breathing (Q3) | ||
| Dergi ISSN | 1520-9512 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 05-2021 |
| Kabul Tarihi | 02-04-2026 | Yayınlanma Tarihi | 28-04-2020 |
| Cilt / Sayı / Sayfa | 25 / 1 / 371–371 | DOI | 10.1007/s11325-020-02087-0 |
| Makale Linki | https://link.springer.com/content/pdf/10.1007/s11325-020-02087-0.pdf | ||
| Özet |
| Dear Editor The publications regarding the continuing of pandemic coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing. Increased age, hypertension, cardiovascular diseases, lung diseases, and diabetes mellitus seem to be the main risk factors for mortality in COVID-19 [1]. However, the possible association between obstructive sleep apnea syndrome (OSAS), repetitive airway collapse with apnea/hypopnea and hypoxia during sleep, and COVID-19 has not been reported yet. Angiotensin converting enzyme 2 (ACE2) is the entry receptor of SARS-CoV-2 [2]. Of note, the increased expression of ACE and dysregulation of renin angiotensin system in untreated OSAS patients due to chronic intermittent hypoxia has been shown [3]. Furthermore, cardiovascular complications or comorbidities such as hypertension, heart failure, coronary … |
| Anahtar Kelimeler |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Google Scholar | 45 |
| Scopus | 3 |
| Web of Science | 21 |